Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes-Reference-Cited by-同舟云学术

Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes

Published:2020-03-02 Issue:3 Volume:15 Page:e0228601
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chimbetete Cleophas^ORCID,Shamu Tinei^ORCID,Keiser Olivia

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study;J Estill;Lancet HIV,2016

2. Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa—A Systematic Review and Meta-Analysis;Y Madec;PLoS One,2013

3. National Medicine and Therapeutics Policy Advisory Committee; The AIDS and TB Directorate Ministry of Health and Child Care;Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe,2013

4. Progress with scale-up of HIV viral load monitoring—seven Sub-Saharan African countries, January 2015–June 2016;S Lecher;Morbidity and Mortality Weekly Report,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological outcomes of third-line antiretroviral therapy in a global context: a systematic reviews and meta-analysis;AIDS Research and Therapy;2024-06-25

2. Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study;PLOS ONE;2024-02-23

3. Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study;2023-10-15

4. HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings;AIDS;2023-08-01

5. Long-term treatment outcome and mutational analysis of patients on third-line antiretroviral therapy in programmatic conditions;Journal of Antimicrobial Chemotherapy;2023-04-12